Download original attachment
(PDF file)
This is an HTML version of an attachment to the Official Information request 'Claims for Medical treatment injury include and the review of product adverse events/effects reports?'.


 
16 November 2023 
 
Erika Whittome 
[FYI request #24496 email] 
 
 
Kia ora Erika 
 
Your Official Information Act request, reference: GOV-028541 
Thank you for your email of 22 October 2022, asking for the following information under the Official 
Information Act 1982 (the Act): 
 
I understand a person may lodge a claim with ACC when there is a medical misadventure. When 
reviewing claims for an adverse event from a medicine, would you kindly share details on this claim 
process. 
 
1. Does ACC review the reports from the product' manufacturer on the product's adverse 
events/effects? 
2. In the case of a provisionally approved medicine (eg Fluvax, Comirnaty), does ACC review the 
Periodic Safety Update reports from the manufacture?  For example, this is a periodic safety report 
from Pfizer on Comirnaty.  
3. Does ACC review the post marketing report published by Pfizer in the case of Comirnaty for claims 
of adverse events for this provisionally approved medicine? Ie this document. 
 
Our response 
Decisions on providing cover for treatment injury claims are made by ACC’s Treatment Injury Claims 
Assessors. They make decisions on an individual basis and will take into consideration any information and 
evidence relevant to the claim. This may include reports and other resources you have noted if they are 
relevant to the claim. ACC has published a previous OIA containing information about the process and 
considerations for treatment injury decisions, here: www.acc.co.nz/assets/oia-responses/policy-and-
procedures-to-assess-treatment-injury-claims-oia-response-GOV-018561.pdf.  
 
As this information may be of interest to other members of the public 
ACC has decided to proactively release a copy of this response on ACC’s website. All requester data, 
including your name and contact details, will be removed prior to release. The released response will be 
made available www.acc.co.nz/resources/#/category/12. 
 
If you have any questions about this response, please get in touch 
You can email me at [email address].  
 
Ngā mihi 
 
Sara Freitag 
Acting Manager Official Information Act Services 
Government Engagement 
 
GOV-028541   Page 1 of 1 

Document Outline